Danaher (NYSE:DHR) issued an update on its third quarter earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.12-1.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.16. Danaher also updated its FY 2019 guidance to $4.75-4.80 EPS.
NYSE DHR traded down $1.04 on Friday, hitting $141.96. The company had a trading volume of 23,047 shares, compared to its average volume of 2,196,764. The stock has a market capitalization of $99.98 billion, a P/E ratio of 31.47, a PEG ratio of 2.53 and a beta of 0.96. The company’s fifty day moving average price is $140.06. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32. Danaher has a 12-month low of $94.59 and a 12-month high of $145.50.
Danaher (NYSE:DHR) last released its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.15 by $0.04. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The business had revenue of $5.16 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same quarter in the prior year, the firm earned $1.15 earnings per share. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. As a group, equities research analysts predict that Danaher will post 4.77 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date of this dividend is Thursday, June 27th. Danaher’s payout ratio is 15.04%.
A number of equities research analysts have recently issued reports on the stock. Robert W. Baird reaffirmed an outperform rating and set a $148.00 target price (up previously from $131.00) on shares of Danaher in a report on Friday. Needham & Company LLC reaffirmed a buy rating and set a $155.00 target price (up previously from $142.00) on shares of Danaher in a report on Friday. Zacks Investment Research lowered shares of GALP ENERGIA SG/ADR from a hold rating to a sell rating in a report on Monday, May 6th. Janney Montgomery Scott upped their target price on shares of Danaher from $136.00 to $174.00 and gave the stock a buy rating in a report on Wednesday, April 17th. Finally, Piper Jaffray Companies raised shares of Post from a neutral rating to an overweight rating and upped their target price for the stock from $106.00 to $130.00 in a report on Thursday. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of $137.08.
In other news, Chairman Mitchell P. Rales acquired 1,900 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The stock was purchased at an average price of $130.78 per share, with a total value of $248,482.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP William King sold 12,950 shares of the company’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $129.92, for a total transaction of $1,682,464.00. Following the completion of the transaction, the senior vice president now directly owns 29,070 shares in the company, valued at approximately $3,776,774.40. The disclosure for this sale can be found here. Insiders sold 453,448 shares of company stock valued at $59,724,640 in the last three months. 11.40% of the stock is currently owned by insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: Fundamental Analysis
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.